Search

Marco M Muda

from San Jose, CA
Age ~63
Get Report
Also known as:
Marco X Muda, Marco N Muda
Related to:
Andrei Matorin, 39Matorin M Yanai, 65
Connected to:
Tarirai Mudadada, 50Tirupati R Mudadla, 61Navraj S Mudahar, 37Juliono E Mudajanto, 54Ashmita Mudaliar, 35Gopu N Mudaliar, 51Monica Mudaliar, 49Parvati Mudaliar, 67Sunder R Mudaliar, 63Manori P Mudalige, 55

Marco Muda Phones & Addresses

  • San Jose, CA
  • New Haven, CT
  • 50 Bow St #9, Somerville, MA 02143
  • 279 Harvard St APT 11, Cambridge, MA 02139 (617) 803-1994
  • 8 Perry St, Brookline, MA 02445 (617) 734-6181
  • 8 Perry St #1, Brookline, MA 02445 (617) 734-6181
  • Quincy, MA
  • Prairie, MS
  • 50 Bow St UNIT 9, Somerville, MA 02143 (617) 734-6181

Work

Company: Abpro Jan 2020 Position: Senior director

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Geneva 1995 to 1997

Skills

Drug Discovery • Biotechnology • Assay Development • Antibodies • Biomarkers • Drug Development • Monoclonal Antibodies • In Vitro • Cell Culture • Molecular Biology • Biopharmaceuticals • Cell Biology • Biochemistry • Life Sciences • Lifesciences • Cell • Immunology • Purification • Proteomics • Protein Chemistry • Clinical Development • Systems Biology • High Throughput Screening • Genomics • Oncology • In Vivo • Immunoassays • Sds Page • Biomarker Discovery • Translational Research • Elisa • Protein Purification • Cancer • Flow Cytometry

Languages

Italian • French • Portuguese

Industries

Biotechnology

Resumes

Resumes

Marco Muda Photo 1

Senior Director

View page
Location:
Somerville, MA
Industry:
Biotechnology
Work:
Abpro
Senior Director
Kleo Pharmaceuticals Inc.
Director of Drug Discovery
Merrimack Nov 1, 2014 - Mar 2018
Investigator and Director
Merrimack Sep 2010 - Nov 2014
Associate Director
Emd Serono, Inc. Jul 2010 - Aug 2010
Associate Director
Education:
University of Geneva 1995 - 1997
Doctorates, Doctor of Philosophy University of Geneva 1994 - 1995
Master of Science, Masters, Medical Biology
Skills:
Drug Discovery
Biotechnology
Assay Development
Antibodies
Biomarkers
Drug Development
Monoclonal Antibodies
In Vitro
Cell Culture
Molecular Biology
Biopharmaceuticals
Cell Biology
Biochemistry
Life Sciences
Lifesciences
Cell
Immunology
Purification
Proteomics
Protein Chemistry
Clinical Development
Systems Biology
High Throughput Screening
Genomics
Oncology
In Vivo
Immunoassays
Sds Page
Biomarker Discovery
Translational Research
Elisa
Protein Purification
Cancer
Flow Cytometry
Languages:
Italian
French
Portuguese

Publications

Us Patents

Fsh Glycosylation Variant D3N

View page
US Patent:
7956034, Jun 7, 2011
Filed:
Jan 16, 2007
Appl. No.:
12/158539
Inventors:
Marco Muda - Cambridge MA, US
Xuliang Jiang - Braintree MA, US
Sean D. McKenna - Duxbury MA, US
Assignee:
Merck Serono SA - Coinsins, Vaud
International Classification:
A61K 38/24
A61K 39/00
A61K 39/385
C12N 5/00
C12N 15/09
C12N 5/07
US Classification:
514 99, 4241981, 4241851, 42419511, 435325, 435 694, 435360, 530398, 530397, 530399
Abstract:
FSH mutant with increased glycosylation and longer half-life is described. The use of this FSH mutant for inducing folliculogenesis in human patients is also described.

Spliced Variants Of Lgr6

View page
US Patent:
20060205924, Sep 14, 2006
Filed:
Dec 23, 2003
Appl. No.:
10/540808
Inventors:
Marco Muda - Brookline MA, US
International Classification:
C07K 14/72
C07H 21/04
C12P 21/06
A61K 48/00
A61K 39/395
C07K 16/28
US Classification:
530350000, 530388220, 424093210, 424143100, 435069100, 435320100, 435325000, 536023500
Abstract:
The present invention provides Leucine-Rich Repeat-Containing G-Protein Coupled Receptor-6 (LGR6-Vs) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing LGR6-SVs polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with LGR6-SVs polypeptides.

Fsh Mutants

View page
US Patent:
20090018070, Jan 15, 2009
Filed:
Dec 21, 2006
Appl. No.:
12/096125
Inventors:
Marco Muda - Brookline MA, US
Xuliang Jiang - Braintree MA, US
Sean D. McKenna - Duxbury MA, US
Assignee:
LABORATOIRES SERONO SA - Coinsins, Vaud
International Classification:
A61K 38/00
C12N 15/11
C12N 15/00
C12N 5/06
A61P 43/00
C07K 14/00
C12P 21/04
US Classification:
514 12, 536 231, 4353201, 435325, 530350, 435 691
Abstract:
FSH mutants with increased glycosylation and longer half-lives are described. The use of FSH mutants for inducing folliculogenesis in human patients is also described.

Anti-Tnfr2 Antibodies And Uses Thereof

View page
US Patent:
20220281990, Sep 8, 2022
Filed:
Feb 28, 2020
Appl. No.:
17/434340
Inventors:
- Cambridge MA, US
- Oakland CA, US
Marco MUDA - New Haven CT, US
James Frank SAMPSON - Medford MA, US
Eric M. TAM - Cooperstown NY, US
Ross Bane FULTON - Southborough MA, US
International Classification:
C07K 16/28
A61P 35/00
A61K 47/42
A61P 37/00
Abstract:
Disclosed herein are anti-TNFR2 antibodies, therapeutic compositions comprising the anti-TNFR2 antibodies, and methods of using such antibodies and compositions in the treatment of cancer and autoimmune diseases.

Anti-Tnfr2 Antibodies And Uses Thereof

View page
US Patent:
20210371537, Dec 2, 2021
Filed:
Sep 18, 2019
Appl. No.:
17/276686
Inventors:
- Cambridge MA, US
Marco MUDA - New Haven CT, US
Klaus Andreas RAUE - Cambridge MA, US
Vinodh B. KURELLA - Malden MA, US
Daryl Clark DRUMMOND - Lincoln MA, US
Ross Bane FULTON - Southborough MA, US
Fabien DEPIS - Brookline MA, US
Anne-Sophie DUGAST - Boston MA, US
Jian TANG - Newton MA, US
Sandeep KUMAR - Lexington MA, US
International Classification:
C07K 16/28
A61K 47/68
A61P 35/00
A61K 39/395
A61P 37/06
Abstract:
Anti-TNFR2 antibodies which bind to particular human TNFR2 epitopes, therapeutic compositions comprising the anti-TNFR2 antibodies, and methods of using such antibodies and compositions in the treatment of cancer are disclosed.

Anti-Fgfr Antibodies And Methods Of Use

View page
US Patent:
20180244785, Aug 30, 2018
Filed:
Jan 8, 2018
Appl. No.:
15/864764
Inventors:
- Cambridge MA, US
Gregory J. FINN - Watertown MA, US
Melissa GEDDIE - Arlington MA, US
Marco MUDA - Somerville MA, US
Birgit M. SCHOEBERL - Cambridge MA, US
International Classification:
C07K 16/28
G01N 33/574
A61P 35/00
A61K 47/68
Abstract:
Anti-FGFR antibodies which bind to particular isoforms of FGFR1-4, therapeutic compositions comprising the anti-FGFR antibodies, and methods of using such antibodies and compositions in the treatment of FGFR-related disorders (e.g., cancer) are disclosed.
Control profile
Marco M Muda from San Jose, CA, age ~63 Get Report